Luis Pérez de Sevilla Müller

Dr. Luis Pérez de Sevilla Müller


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2013 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
ARAllen R. Rodriguez
Allen R. Rodriguez
LMLuis Pérez de Sevilla Müller
Luis Pérez de Sevilla Müller
NBNicholas C. Brecha
Nicholas C. Brecha

12 September 2007 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
LMLuis Pérez de Sevilla Müller
Luis Pérez de Sevilla Müller
JSJennifer Shelley
Jennifer Shelley
RWReto Weiler
Reto Weiler

26 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LMLuis Pérez de Sevilla Müller
Luis Pérez de Sevilla Müller
ASAllison Sargoy
Allison Sargoy
ARAllen R. Rodriguez
Allen R. Rodriguez
NBNicholas C. Brecha
Nicholas C. Brecha
We report that the most common retinal ganglion cell type that remains after optic nerve transection is the M1 melanopsin ganglion cell. M1 ganglion cells are members of the intrinsically photosensitive retinal ganglion cell population that mediates non-image-forming vision, comprising ∼2.5% of all ganglion cells in the rat retina. In the present study, M1 ganglion cells comprised 1.7±1%, 28±14%, 55±13% and 82±8% of the surviving ganglion cells 7, 14, 21 and 60 days after optic nerve transection, respectively. Average M1 ganglion cell somal diameter and overall morphological appearance remained unchanged in non-injured and injured retinas, suggesting a lack of injury-induced degeneration. Average M1 dendritic field size increased at 7 and 60 days following optic nerve transection, while average dendritic field size remained similar in non-injured retinas and in retinas at 14 and 21 days after optic nerve transection. These findings demonstrate that M1 ganglion cells are more resistant to injury than other ganglion cell types following optic nerve injury, and provide an opportunity to develop pharmacological or genetic therapeutic approaches to mitigate ganglion cell death and save vision following optic nerve injury.

5 May 2017 in Frontiers in Neuroanatomy
Verified
Journal Article
Open access
LMLuis Pérez de Sevilla Müller
Luis Pérez de Sevilla Müller
SAShaghauyegh S. Azar
Shaghauyegh S. Azar
JSJanira de Los Santos
Janira de Los Santos
NBNicholas C. Brecha
Nicholas C. Brecha
The transcription factor Prox1 is expressed in multiple cells in the retina during eye development. This study has focused on neuronal Prox1 expression in the inner nuclear layer (INL) of the adult mouse retina. Prox1 immunostaining was evaluated in vertical retinal sections and whole mount preparations using a specific antibody directed to the C-terminus of Prox1. Strong immunostaining was observed in numerous amacrine cell bodies and in all horizontal cell bodies in the proximal and distal INL, respectively. Some bipolar cells were also weakly immunostained. Prox1-immunoreactive amacrine cells expressed glycine, and they formed 35±3% of all glycinergic amacrine cells. Intracellular Neurobiotin injections into AII amacrine cells showed that all gap junction-coupled AII amacrine cells express Prox1, and no other Prox1-immunostained amacrine cells were in the immediate area surrounding the injected AII amacrine cell. Prox1-immunoreactive amacrine cell bodies were distributed across the retina, with their highest density (3887±160 cells/mm2) in the central retina, 0.5 mm from the optic nerve head, and their lowest density (3133±350 cells/mm2) in the mid-peripheral retina, 2 mm from the optic nerve head. Prox1-immunoreactive amacrine cell bodies comprised ~9.8% of the total amacrine cell population, and they formed a non-random mosaic with a regularity index of 3.4, similar to AII amacrine cells in the retinas of other mammals. Together, these findings indicate that AII amacrine cells are the predominant and likely only amacrine cell type strongly expressing Prox1 in the adult mouse retina, and establish Prox1 as a marker of AII amacrine cells.

2 January 2024 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
AMAnna Matynia
Anna Matynia
BRBrandy S. Recio
Brandy S. Recio
ZMZachary Myers
Zachary Myers
SPSachin Parikh
Sachin Parikh
RGRajesh Kumar Goit
Rajesh Kumar Goit
LMLuis Pérez de Sevilla Müller
Luis Pérez de Sevilla Müller
Purpose: Intrinsically photosensitive retinal ganglion cells (ipRGCs) play a crucial role in non–image-forming visual functions. Given their significant loss observed in various ocular degenerative diseases at early stages, this study aimed to assess changes in both the morphology and associated behavioral functions of ipRGCs in mice between 6 (mature) and 12 (late adult) months old. The findings contribute to understanding the preservation of ipRGCs in late adults and their potential as a biomarker for early ocular degenerative diseases. Methods: Female and male C57BL/6J mice were used to assess the behavioral consequences of aging to mature and old adults, including pupillary light reflex, light aversion, visual acuity, and contrast sensitivity. Immunohistochemistry on retinal wholemounts from these mice was then conducted to evaluate ipRGC dendritic morphology in the ganglion cell layer (GCL) and inner nuclear layer (INL). Results: Morphological analysis showed that ipRGC dendritic field complexity was remarkably stable through 12 months old of age. Similarly, the pupillary light reflex, visual acuity, and contrast sensitivity were stable in mature and old adults. Although alterations were observed in ipRGC-independent light aversion distinct from the pupillary light reflex, aged wild-type mice continuously showed enhanced light aversion with dilation. No effect of sex was observed in any tests. Conclusions: The preservation of both ipRGC morphology and function highlights the potential of ipRGC-mediated function as a valuable biomarker for ocular diseases characterized by early ipRGC loss. The consistent stability of ipRGCs in mature and old adult mice suggests that detected changes in ipRGC-mediated functions could serve as early indicators or diagnostic tools for early-onset conditions such as Alzheimer's disease, Parkinson's disease, and diabetes, where ipRGC loss has been documented.

1 January 2026 in Neurobiology of Aging
Verified
Journal Article
Closed access
BRBrandy S. Recio
Brandy S. Recio
WPWilliam A. Pérez
William A. Pérez
RTRuth Tjondropurnomo
Ruth Tjondropurnomo
JHJenibelle Hsu
Jenibelle Hsu
SASimrah Ahmed
Simrah Ahmed
LMLuis Pérez de Sevilla Müller
Luis Pérez de Sevilla Müller